Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts

Critical Care Medicine

Volumn 31, Issue 3, 2003, Pages 683-688

  Sibelius, Ulf ^a   Grandel, Ulrich ^a   Buerke, Michael ^b   Kiss, Ladislau ^a   Klingenberger, Pascal ^a   Heep, Martina ^a   Bournelis, Emmanoyil ^a   Seeger, Werner ^a   Grimminger, Friedrich ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Department of Internal Medicine ^*  (Germany)

Author keywords

Coronary circulation; Escherichia coli; Exotoxins; Heart failure; Leukotrienes; Septic; Shock

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CREATINE KINASE; EXOTOXIN; HEMOLYSIN; INDOMETACIN; LACTATE DEHYDROGENASE; LEUKOTRIENE; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LIPOXYGENASE INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE A2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DOSE RESPONSE; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME RELEASE; ESCHERICHIA COLI; FLOW KINETICS; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HEART WEIGHT; HEMOLYSIS; INFECTION; ISOLATED HEART; MALE; MEDIATOR RELEASE; NONHUMAN; PATHOGENESIS; PERFUSION PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; RAT; SEPSIS; SEPTIC SHOCK; UNIVERSITY HOSPITAL; VASOCONSTRICTION;

ANIMALS; CORONARY CIRCULATION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EXOTOXINS; HEART FAILURE, CONGESTIVE; HEMOLYSIN PROTEINS; INDOLES; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; MALE; MYOCARDIAL CONTRACTION; PROSPECTIVE STUDIES; RATS; SHOCK, SEPTIC; VASOCONSTRICTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FIBRILLATION; VENTRICULAR PRESSURE;

EID: 0037350243     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000050072.69509.06     Document Type: Article

References (59)

1. Parrillo JE: Pathogenic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
2. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
3. Kumar A, Parrillo JE: Clinical manifestations of cardiovascular dysfunctions in sepsis. In: Pathophysiology of Shock, Sepsis, and Organ Failure. Schlag G, Redl H (Eds). Berlin, Heidelberg, Springer-Verlag, 1993, pp 859-881
4. Parker MM, McCarthy KE, Ognibene FP: Right ventricular dysfunction and dilation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest 1990; 97:126-131
5. Parrillo JE, Burch C, Shelhamer JH, et al: A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985; 76:1539-1553
6. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor-α and interleukin 1β are responsible for in vitro myocardial depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
7. 2 and sphingosine. Br J Pharmacol 1998; 124:493-498
8. Edmunds NJ, Lal H, Woodward B: Effects of tumour necrosis factor-α on left ventricular function in the rat isolated perfused heart: Possible mechanisms for a decline in cardiac function. Br J Pharmacol 1999; 126:189-196
9. Stein B, Frank P, Schmitz W, et al: Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996; 28:1631-1639
10. Oral H, Dorn GW II, Mann DL: Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 1997; 272:4836-4842
11. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105:575-580
12. Gulick T, Chung MK, Pieper SJ, et al: Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci U S A 1989; 86:6753-6757
13. Bozkurt B, Kribbs SB, Clubb FJ, et al: Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97:1382-1391
14. Edmunds NJ, Lal H, Woodward B: Effects of tumour necrosis factor-α on left ventricular function in the rat isolated perfused heart: Possible mechanisms for a decline in cardiac function. Br J Pharmacol 1999; 126:189-196
15. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993; 92:2303-2312
16. Oral H, Dorn GW II, Mann DL: Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 1997; 272:4836-4842
17. Hersch M, Gnidec AA, Bersten AD, et al: Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 1990; 107:397-410
18. Avontuur JAM, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995; 76:418-425
19. Groenevald ABJ, van Lambalgen AA, van den Bos GC, et al: Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 1991; 25:80-88
20. Fox GA, Bersten A, Lam C, et al: Hematocrit modifies the circulatory control of systemic and myocardial oxygen utilization in septic sheep. Crit Care Med 1994; 22:470-479
21. Bloos FM, Morisaki HM, Neal AM, et al: Sepsis depresses the metabolic oxygen reserve of the coronary circulation in mature sheep. Am J Respir Crit Care Med 1996; 153:1577-1584
22. Raper RF, Sibbald WJ, Hobson J, et al: Changes in myocardial blood flow during hyperdynamic sepsis with induced changes in arterial perfusing pressures and metabolic need. Crit Care Med 1993; 21:1192-1199
23. Hersch M, Gnidec AA, Bersten AD, et al: Histologic and ultrastructural changes in nonpulmonary organs during early hyperdynamic sepsis. Surgery 1990; 107:397-410
24. Groeneveld ABJ, Van Lambalgen AA, van den Bos GC, et al: Maldistribution of heterogeneous coronary blood flow during canine endotoxin shock. Cardiovasc Res 1991; 25:80-88
25. Sibelius U, Grandel U, Buerke M, et al: Staphylococcal α-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts - Role of thromboxane formation. Circulation 2000; 101:78-85
26. Bhakdi S, Greulich S, Muhly M, et al: Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J Exp Med 1989; 169:737-754
27. Bhakdi S, Mackmann N, Menestrina G, et al: The hemolysin of Escherichia coli. Eur J Epidemiol 1988; 4:135-143
28. Cavalieri SJ, Bohach GA, Snyder IS: Escherichia coli α-hemolysin: Characteristics and probable role in pathogenicity. Microbiol Rev 1984; 48:326-343
29. Welch RA, Dellinger EP, Minshew B, et al: Hemolysin contributes to virulence of extraintestinal E. coli infections. Nature 1981; 294:665-667
30. Grimminger F, Sibelius U, Bhakdi S, et al: Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J Clin Invest 1991; 88:1531-1539
31. Grimminger F, Scholz C, Bhakdi S, et al: Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils. J Biol Chem 1991; 266:14262-14269
32. Suttorp N, Flör B, Schnittler H, et al: Effects of Escherichia coli hemolysin on endothelial cell function. Infect Immun 1990; 58:3796-3801
33. Suttorp N, Fuhrmann M, Tannert-Otto S, et al: Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J Exp Med 1993; 178:337-341
34. Grimminger F, Rose F, Sibelius U, et al: Human endothelial cell activation and mediator release in response to the bacterial exotoxins Escherichia coli hemolysin and staphylococcal α-toxin. J Immunol 1997; 159:1909-1916
35. Kiss L, Bieniek E, Weissmann N, et al: Simultaneous analysis of 4- and 5-series lipoxygenase and cytochrome P-450 products from different biological sources by reversed-phase high-performance liquid chromatographic technique. Anal Biochem 1998; 261:16-28
36. Eberspächer B, Hugo F, Pohl M, et al: Functional similarity between the hemolysins of Escherichia coli and Morganella morganii. J Med Microbiol 1990; 33:165-170
37. Koronakis V, Cross M, Senior B, et al: The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J Bacteriol 1987; 169:1509-1515
38. Lalonde G, McDonald TV, Gardner P, et al: Identification of a hemolysin from Actinobacillus pleuropneumoniae and characterization of its channel properties in planar phospholipid bilayers. J Biol Chem 1989; 264:13559-135564
39. Bhakdi S, Muhly M, Korom S, et al: Release of interleukin 1β associated with potent action of staphylococcal alpha-toxin on human monocytes. Infect Immun 1989; 57:3512-3519
40. Seeger W, Walter H, Suttorp N, et al: Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs. J Clin Invest 1989; 84:220-227
41. Hammarstrom S: Leukotrienes. Annu Rev Biochem 1983; 52:355-377
42. Garlick PB, Mashiter GD, DiMarzo V, et al: The synthesis, release and action of leukotrienes in the isolated, unstimulated, buffer-perfused rat heart. J Mol Cell Cardiol 1989; 21:1101-1110
43. Feuerstein G, Hallenbeck JM: Leukotrienes in health and disease. FASEB J 1987; 1:186-192
44. Lee CC, Appleyard RF, Byrne JG, et al: Leukotrienes D4 and E4 produced in myocardium impair coronary flow and ventricular function after two hours of global ischaemia in rat heart. Cardiovasc Res 1993; 27:770-773
45. Gok S, Ulker S, Huseyinov A, et al: Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: Effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase. Pharmacology 2000; 60:41-46
46. Evers AS, Murphree S, Saffitz JE, et al: Effects of endogenous produced leukotrienes, thromboxane and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 1985; 75:992-999
47. Barst S, Mullane K: The release of a leukotriene D4 like substance following myocardial infarction. Eur Pharmacol 1985; 114:383-387
48. Keller AM, Clancy RM, Barr ML, et al: Acute reoxygenation injury in the isolated rat: Role of resident cardiac mast cells. Circ Res 1988; 63:1044-1052
49. Rosenbaum D, Levitsky S, Silverman N: Cardioplegia does not prevent reperfusion injury induced by intracoronary platelet deposition. Circulation 1983; 68:102-106
50. Stahl R, Deutsch E, Fishes C, et al: Cardiac ischemia and endothelial function in the isolated rabbit heart. J Surg Res 1989; 47:94-104
51. Schror K: Prostaglandins, other eicosanoids and endothelial cells. Basic Res Cardiol 1985; 80:502-514
52. Kuhn H, Punicke K, Kalle W, et al: Evidence for the presence of lipoxygenase pathway in cultured endothelial cells. Biomed Biochim Acta 1983; 5:K1-K4
53. Hogaboom GK, Mong S, Stadel JM, et al: Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cation and sulphydryl-directed reagents. Mol Pharmacol 1985; 27:236-245
54. Hogaboom GK, Mong S, Stadel JM, et al: Characterization of [3H] leukotriene D4 binding sites in guinea pig ventricular myocardium. Mol Pharmacol Exp Ther 1985; 233:686-693
55. Sala A, Rossoni G, Buccellati C, et al: Formation of sulphidopeptide-leukotrienes by cell-cell interaction causes coronary vasoconstriction in isolated, cell-perfused heart of rabbit. Br J Pharmacol 1993; 110:1206-1212
56. 4 transfer. Blood 1988; 72:1687-1692
57. 4 synthesized by polymorphonuclear leukocytes. J Biol Chem 1986; 261:16466-16472
58. Karmazyn M: Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion. Can J Physiol 1989; 67:912-921
59. Roth DM, Lefer DJ, Hock CE, et al: Effects of peptide leukotriene synthesis on cardiac dynamics in rat, cat, and guinea pig hearts. Am J Physiol 1985; 249:1206-1212